or
Bookmark and Share
Multicyclic nitrone spin trapping compositions
   
Document Number
US Patent 5900227
Issued Date
May 4, 1999
Link
Inventors
Janzen; Edward G. (Oklahoma City, OK)
Map
Abstract
Multicyclic nitrone spin trapping compounds capable of forming stable free radical spin adducts are provided as well as methods for their synthesis. The multicyclic nitrone spin trapping compounds can be reacted with a free radical, such as a hydroxy or hydroperoxy radical, in solution to form a spin adduct which is stable and readily detectable by electron paramagnetic resonance (EPR) spectroscopy. The multicyclic nitrone spin traps can be used to detect free radicals in a sample such as a biological system. In one embodiment, the spin trapping compound, 1,3,3-trimethyl-6-azabicyclo-[3.2.1]oct-6-ene-N-oxide ("TRAZON") is provided, as well as methods for the synthesis of TRAZON and of modified forms of TRAZON. TRAZON can react with a wide range of different free radicals in solution to form free radical spin adducts which are readily detectable by EPR.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
22
Comments:
no comments yet
Owner
Published
May 4, 1999
Application Number
08/664,450
Filed
June 17, 1996
US Classification
424/9.33   540/450 540/451
Int'l Classification
C07D   209/52   (20060101)   C07D   209/00   (20060101)   A61K   49/20   (20060101)   A61K   49/00   (20060101)   A61K   49/06   (20060101)   C07D   221/00   (20060101)   C07D   221/24   (20060101)  
Examiner
Assistant Examiner
USPTO Field of Search
424/1.11   424/1.65   424/9.3   424/9.33   514/79   514/83   540/1   540/450   540/451   540/454   540/455   540/456  
Related Patents
7022729 - Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists - Owned by Merz Pharma GmbH & Co. KGAA (Franfurt am Main,DE)

Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexanes which are systemically-active as NMDA, 5HT.sub.3, and nicotinic receptor antagonists, pharmaceutical compositions comprising the same, method of preparation thereof, and method of treating CNS disorders which involve disturbances of glutamatergic, serotoninergic, and nicotinic transmission, treating immunomodulatory disorders, and antimalaria, antitrypanosomal, anti-Borna virus, anti-HSV and anti-Hepatitis C virus activity.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us